Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Cerevel Therapeutics Holdings, Inc. (CERE)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
4 Mar 2024
COLES N ANTHONY
Director
Cerevel Therapeutics Holdings, Inc.
(CERE)
15,638
-76%
50,000
$41.01
$2,050,550.10
SELL
29 Feb 2024
COLES N ANTHONY
Director
Cerevel Therapeutics Holdings, Inc.
(CERE)
15,638
-76%
50,000
$41.16
$2,057,890.00
SELL
6 Feb 2024
COLES N ANTHONY
Director
Cerevel Therapeutics Holdings, Inc.
(CERE)
15,638
-13%
2,506
$41.54
$104,109.52
SELL
6 Feb 2024
Renger John
Chief Scientific Officer, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
6,370
-25%
2,161
$41.54
$89,776.81
SELL
2 Jan 2024
COLES N ANTHONY
Director
Cerevel Therapeutics Holdings, Inc.
(CERE)
2,704
-94%
50,000
$42.24
$2,111,815.00
SELL
26 Dec 2023
Sanchez Ramiro
Chief Medical Officer, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
14,673
-40%
10,000
$42.47
$424,700.00
SELL
22 Dec 2023
DiPietro Kenneth
Chief Human Resources Officer, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
24,663
-24%
8,000
$41.45
$331,608.00
SELL
19 Dec 2023
Tregoning Kathleen
See Remarks, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
7,516
-45%
6,288
$41.42
$260,469.08
SELL
19 Dec 2023
ALTSCHULLER Susan
Chief Financial Officer, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
16,913
-44%
13,808
$41.42
$571,971.50
SELL
19 Dec 2023
Sanchez Ramiro
Chief Medical Officer, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
14,673
-40%
10,152
$41.42
$420,528.30
SELL
19 Dec 2023
Akamine Scott
Chief Legal Officer, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
7,237
-49%
7,072
$41.42
$292,944.88
SELL
19 Dec 2023
DiPietro Kenneth
Chief Human Resources Officer, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
24,663
-20%
6,256
$41.42
$259,143.53
SELL
19 Dec 2023
Bodenrader Mark
See Remarks, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
17,724
-30%
7,889
$41.42
$326,787.62
SELL
15 Dec 2023
Sanchez Ramiro
Chief Medical Officer, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
0
-100%
7,500
$41.39
$310,392.75
SELL
14 Nov 2023
COLES N ANTHONY
Director
Cerevel Therapeutics Holdings, Inc.
(CERE)
2,704
-89%
22,824
$25.13
$573,455.25
SELL
7 Nov 2023
COLES N ANTHONY
Director
Cerevel Therapeutics Holdings, Inc.
(CERE)
2,704
-90%
27,176
$25.02
$680,071.25
SELL
2 Nov 2023
COLES N ANTHONY
Director
Cerevel Therapeutics Holdings, Inc.
(CERE)
2,704
-97%
100,000
$25.34
$2,533,697.50
SELL
1 Nov 2023
PATRICK DEVAL L
Director
Cerevel Therapeutics Holdings, Inc.
(CERE)
3,282
-90%
30,130
$25.00
$753,250.00
SELL
7 Sep 2023
COLES N ANTHONY
Director
Cerevel Therapeutics Holdings, Inc.
(CERE)
2,704
-94%
50,000
$24.07
$1,203,415.00
BUY
4 Aug 2023
Burgess Paul D.
See Remarks, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
21,880
+100%
21,880
$22.93
$501,793.75
BUY
3 Aug 2023
Renaud Ronald C JR
President & CEO, Director, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
83,857
+100%
83,857
$23.96
$2,008,811.20
SELL
11 Jul 2023
COLES N ANTHONY
Director
Cerevel Therapeutics Holdings, Inc.
(CERE)
2,704
-94%
50,000
$30.03
$1,501,340.00
SELL
15 Jun 2023
DEKKERS MARIJN E
Director
Cerevel Therapeutics Holdings, Inc.
(CERE)
402,326
-33%
200,000
$34.43
$6,886,000.00
SELL
1 Jun 2023
Bodenrader Mark
See Remarks, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
5,522
-25%
1,895
$32.95
$62,440.25
SELL
1 Jun 2023
COLES N ANTHONY
CEO and Chairperson, Director, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
2,704
-94%
50,000
$32.60
$1,630,069.90
SELL
4 May 2023
COLES N ANTHONY
CEO and Chairperson, Director, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
15,136
-76%
50,000
$31.47
$1,573,433.60
SELL
11 Apr 2023
COLES N ANTHONY
CEO and Chairperson, Director, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
2,704
-94%
50,000
$25.06
$1,253,130.00
SELL
2 Mar 2023
COLES N ANTHONY
CEO and Chairperson, Director, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
2,704
-94%
50,000
$27.12
$1,355,946.90
SELL
6 Feb 2023
COLES N ANTHONY
CEO and Chairperson, Director, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
10,646
-82%
50,000
$33.13
$1,656,400.80
SELL
5 Jan 2023
COLES N ANTHONY
CEO and Chairperson, Director, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
3,204
-93%
50,000
$29.94
$1,496,871.20
SELL
9 Dec 2022
COLES N ANTHONY
CEO and Chairperson, Director, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
7,849
-86%
50,000
$26.67
$1,333,300.00
SELL
1 Nov 2022
Renger John
Chief Scientific Officer, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
2,704
-90%
25,000
$30.00
$750,005.00
SELL
4 Oct 2022
Renger John
Chief Scientific Officer, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
2,704
-90%
25,000
$30.00
$750,000.00
SELL
12 Sep 2022
PATRICK DEVAL L
Director
Cerevel Therapeutics Holdings, Inc.
(CERE)
0
-100%
47,705
$30.78
$1,468,421.90
BUY
16 Aug 2022
PERCEPTIVE ADVISORS LLC
Director
Cerevel Therapeutics Holdings, Inc.
(CERE)
6,511,727
+28%
1,425,000
$35.00
$49,875,000.00
SELL
15 Aug 2022
Ceesay Abraham
President, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
0
-100%
9,606
$34.12
$327,756.72
SELL
10 Aug 2022
Renger John
Chief Scientific Officer, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
21,563
-71%
55,000
$40.50
$2,227,623.80
SELL
20 Jul 2022
Renger John
Chief Scientific Officer, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
2,704
-90%
25,000
$30.00
$750,000.00
SELL
5 Jul 2022
Renger John
Chief Scientific Officer, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
2,704
-90%
26,105
$30.11
$785,912.50
SELL
13 Apr 2022
Renger John
Chief Scientific Officer, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
1,980
-95%
45,000
$34.65
$1,559,092.50
SELL
29 Mar 2022
Renger John
Chief Scientific Officer, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
1,980
-83%
10,000
$35.00
$350,000.00
SELL
16 Mar 2022
Renger John
Chief Scientific Officer, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
1,980
-95%
45,000
$31.11
$1,400,009.00
SELL
9 Mar 2022
Renger John
Chief Scientific Officer, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
11,980
-71%
30,000
$33.33
$1,000,000.00
SELL
2 Mar 2022
Renger John
Chief Scientific Officer, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
1,980
-92%
25,000
$30.00
$750,000.00
SELL
9 Feb 2022
Renger John
Chief Scientific Officer, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
1,980
-92%
25,000
$30.00
$750,000.00
SELL
23 Dec 2021
Renger John
Chief Scientific Officer, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
1,980
-83%
10,000
$35.00
$350,027.00
SELL
21 Dec 2021
Renger John
Chief Scientific Officer, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
1,980
-78%
7,300
$32.50
$237,250.00
SELL
15 Dec 2021
Renger John
Chief Scientific Officer, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
1,980
-95%
37,700
$30.85
$1,163,197.50
SELL
10 Nov 2021
Renger John
Chief Scientific Officer, Officer
Cerevel Therapeutics Holdings, Inc.
(CERE)
31,368
-63%
55,000
$39.86
$2,192,187.20
BUY
26 Aug 2021
PERCEPTIVE ADVISORS LLC
Director
Cerevel Therapeutics Holdings, Inc.
(CERE)
5,086,727
+1%
68,047
$30.23
$2,057,060.80
BUY
23 Aug 2021
PERCEPTIVE ADVISORS LLC
Director
Cerevel Therapeutics Holdings, Inc.
(CERE)
5,018,680
+3%
175,585
$27.53
$4,833,885.00
BUY
7 Jul 2021
PERCEPTIVE ADVISORS LLC
Director
Cerevel Therapeutics Holdings, Inc.
(CERE)
4,843,095
+4%
200,000
$25.00
$5,000,000.00
BUY
17 Jun 2021
Sulzberger Gabrielle
Director
Cerevel Therapeutics Holdings, Inc.
(CERE)
35,354
+147%
21,084
$13.06
$275,357.06
BUY
9 Nov 2020
Gordon Christopher R
Director, 10% Owner
Cerevel Therapeutics Holdings, Inc.
(CERE)
60,632,356
+0%
332,293
$10.30
$3,422,618.00
BUY
9 Nov 2020
BAIN CAPITAL INVESTORS LLC
10% Owner
Cerevel Therapeutics Holdings, Inc.
(CERE)
60,632,356
+0%
332,293
$10.30
$3,422,618.00
BUY
9 Nov 2020
Koppel Adam
Director, 10% Owner
Cerevel Therapeutics Holdings, Inc.
(CERE)
60,632,356
+0%
332,293
$10.30
$3,422,618.00
BUY
27 Oct 2020
Gordon Christopher R
Director, 10% Owner
Cerevel Therapeutics Holdings, Inc.
(CERE)
60,300,064
+19%
10,000,000
$10.00
$100,000,000.00
BUY
27 Oct 2020
PFIZER INC
10% Owner
Cerevel Therapeutics Holdings, Inc.
(CERF)
27,349,212
+4%
1,200,000
$10.00
$12,000,000.00
BUY
27 Oct 2020
PERCEPTIVE ADVISORS LLC
Director
Cerevel Therapeutics Holdings, Inc.
(CERE)
3,157,295
+1907%
3,000,000
$10.00
$30,000,000.00
BUY
27 Oct 2020
BAIN CAPITAL INVESTORS LLC
10% Owner
Cerevel Therapeutics Holdings, Inc.
(CERE)
60,300,064
+19%
10,000,000
$10.00
$100,000,000.00
BUY
27 Oct 2020
Koppel Adam
Director, 10% Owner
Cerevel Therapeutics Holdings, Inc.
(CERE)
60,300,064
+19%
10,000,000
$10.00
$100,000,000.00
BUY
20 Oct 2020
PERCEPTIVE ADVISORS LLC
Director
ARYA Sciences Acquisition Corp II
(ARYB)
157,295
+100%
157,295
$10.02
$1,576,837.50
Home